imipramine has been researched along with antimony sodium gluconate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dujardin, JC; Mukherjee, B; Mukherjee, S; Mukhopadhyay, R; Naskar, K; Roy, S; Sundar, S | 1 |
| Ghosh, R; Ghosh, S; Juin, SK; Majumdar, S; Majumdar, SB; Roy, N | 1 |
2 other study(ies) available for imipramine and antimony sodium gluconate
| Article | Year |
|---|---|
Imipramine exploits histone deacetylase 11 to increase the IL-12/IL-10 ratio in macrophages infected with antimony-resistant Leishmania donovani and clears organ parasites in experimental infection.
Topics: Acetylation; Animals; Antibodies; Antimony; Antimony Sodium Gluconate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Cricetinae; Drug Resistance; Histone Deacetylase 6; Histone Deacetylases; Imipramine; Interleukin-10; Interleukin-12; Interleukin-12 Subunit p35; Interleukin-12 Subunit p40; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mice; Mice, Inbred BALB C; NF-kappa B p50 Subunit; Promoter Regions, Genetic; Signal Transduction; T-Lymphocytes; Transcription Factor RelA; Trypanocidal Agents | 2014 |
Immunomodulator mediated changes in plasma membrane calcium ATPase in controlling visceral leishmaniasis.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Calcium; Calcium-Transporting ATPases; Cell Line; Cell Membrane; Ceramides; Culture Media, Serum-Free; Densitometry; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Glycyrrhizic Acid; Imipramine; Immunoblotting; Immunologic Factors; Leishmania donovani; Leishmaniasis, Visceral; Lipopolysaccharides; Macrophages; Mice; Reverse Transcriptase Polymerase Chain Reaction; Reverse Transcription; RNA, Protozoan; RNA, Small Interfering; Transfection | 2020 |